Wrzeszcz, K.; Słomka, A.; Zarychta, E.; Rhone, P.; Ruszkowska-Ciastek, B.
Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study. J. Clin. Med. 2022, 11, 2398.
https://doi.org/10.3390/jcm11092398
AMA Style
Wrzeszcz K, Słomka A, Zarychta E, Rhone P, Ruszkowska-Ciastek B.
Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study. Journal of Clinical Medicine. 2022; 11(9):2398.
https://doi.org/10.3390/jcm11092398
Chicago/Turabian Style
Wrzeszcz, Katarzyna, Artur Słomka, Elżbieta Zarychta, Piotr Rhone, and Barbara Ruszkowska-Ciastek.
2022. "Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study" Journal of Clinical Medicine 11, no. 9: 2398.
https://doi.org/10.3390/jcm11092398
APA Style
Wrzeszcz, K., Słomka, A., Zarychta, E., Rhone, P., & Ruszkowska-Ciastek, B.
(2022). Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study. Journal of Clinical Medicine, 11(9), 2398.
https://doi.org/10.3390/jcm11092398